• Small Molecules
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers

Press Kit

Essential resources, including the corporate fact sheet, the ESG report, and other collaterals offering a comprehensive overview of the company.

Building a Better Tomorrow: Syngene’s ESG Impact

Syngene has taken significant strides to embed sustainability into its operations. At Syngene, we believe that scientific innovation and environmental responsibility go hand-in-hand. Over the past year, we sourced 92% of our electricity from renewable sources, reduced freshwater consumption by 64%, and continued to maintain zero waste to landfill across all our campuses. A major milestone was the validation of our near-term greenhouse gas (GHG) reduction targets by the Science Based Targets initiative (SBTi). We are now working towards a 54.6% reduction in Scope 1 and 2 emissions by 2033.

Syngene's U.S Biologics Facility

Biologics Factsheet

Development and Manufacturing Services Factsheet

Discovery Services Factsheet

Leadership Team

Syngene Annual Report: FY24

Syngene Advantage

Biologics Factsheet

To view or email, Please share your details view

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details